| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.048 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |